Medical
About Us

Investor Relations
In response to changes in the business environment and to incorporate a sustainability management perspective, our Group has clearly defined its vision for 2030 as “EIKEN Vision 2030”.
Our Group has formulated a new management plan, "Management Plan 2030", as its strategic roadmap toward fiscal year 2030.
The plan sets forth three priority strategies: "Improvement of earning power of domestic business", "Accelerated growth of overseas business", and "Non-continuous growth through alliances and M&As". Through these initiatives, we aim to realize sustainable growth and improved profitability.
| FY2030 | |
|
Sales |
50 billion yen + Excluding new businesses and non-continuous growth |
|
Overseas sales ratio |
7 billion yen + |
|
Operating profit |
14% + |
| ROE | 10% + |
| ROIC | 10% + |
FY (Fiscal Year) refers to the Company’s defined fiscal year, and FY2030 corresponds to the fiscal year ending March 31, 2031.
Management
policy
Stock
Information